Telik

Icahn Has Stake in Drug Maker: Filing

by Christopher Glynn, Reporter November 19, 2008 Carl Icahn has bought up stock in a drug maker again. This time, the corporate raider has taken a stake in Exelixis Inc., a San Francisco company specializing in cancer...

Telik to provide new TRAP drug discovery technology to HSS investigators

Palo Alto, California Telik, Inc. announced an agreement to provide its TRAP drug discovery technology to investigators at the Hospital for Special Surgery (HSS). The Research Division of HSS studies the mechanisms underlying...

Telik Announces New TRAP Drug Discovery Agreement

PALO ALTO, Calif., November 12, 2008 /PRNewswire-FirstCall/ -- Telik, Inc. announced today an agreement to provide its TRAP(R) drug discovery technology to investigators at the Hospital for Special Surgery (HSS). HSS...

Telik Q3 loss narrows to $8M (at bizjournals.com)

Silicon Valley / San Jose Business Journal on Wednesday reported a third quarter loss of $8 million, or 15 cents a share, compared to a loss in the same period last year of $11.6 million, or 22 cents a share in the same period...

Telik Announces Financial Results for 2008 Third Quarter (PR Newswire)

Telik, Inc. reported a net loss of $8.0 million, or $0.15 per share, for the third quarter ended September 30, 2008, compared with a net loss of $11.6 million, or $0.22 per share, for the comparable period in 2007.